AWS has supported this highly-invested UK start-up with a clear manufacturing strategy to aid their cutting-edge biometric technology, recognising ‘speed to market’ as a critical factor in the success of a new product launch.
AWS’ vast experience within the medical devices industry, coupled with its ISO 13485 and ISO 9001:2015 accreditations, make AWS the perfect partner in the complex PCBA and unit assembly required for the ground-breaking device.
Paul Deehan, CEO, comments: “We are delighted once again to be working with a revolutionary start-up in the medical sector, supporting a company with fantastic IPR, who are using modern technology in and around real-time monitoring of blood glucose and ketones in patients.”
AWS provide services for the entire electronic product life-cycle and are therefore fully equipped to support this fast-growing organisation as they move from NPI requirements to higher volume manufacturing needs. AWS also provide the opportunity, where required, to move production to its low-cost manufacturing facility in Námestovo, Slovakia.
